Vertex Pharmaceuticals Inc. closed 10.89% short of its 52-week high of $519.88, which the company achieved on November 8th.

Following our analysis of the options activities associated with Vertex Pharmaceuticals, we pivot to a closer look at the company's own performance. Where Is Vertex Pharmaceuticals Standing Right Now?

Valued at a market cap of $117.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company that ...

This was the stock's second consecutive day of gains.

U.S. | U.S. multinational company Abbott entered a partnership with Abu Dhabi's Department of Health to manufacture medicines in the United Arab Emirates capital as part of the country’s effort ...

Particularly at risk is the basic research category, where a lot of health research projects fall. (New York Times) To read last Friday’s edition of Five things for pharma marketers to know, click ...

Unlike traditional video tools that require separate audio work, the Veo 3 API generates videos with natural, perfectly-timed sound. Dialogue, ambient noise, and even subtle audio cues are built ...

Wiim, my favorite audio brand, just dropped the prices on every single one of its devices in the Prime Day sale.

The pharmaceutical industry is today faced with fears about the loss of connection and alignment between patients, providers and biotech companies. Today’s patient care journey is delayed, impersonal ...

Robinson Pharma has clarified that it bears no association with or liability for products bearing the brand's name or ingredients if sold outside its official distribution channels.

Lilly's new plant in North Carolina, which is the company's second in the state, uses a mix of automation and robotics to crank out injectable drugs.

dbrand's Killswitch case for Nintendo Switch 2 has a major flaw, and the company's only now admitting that its original response was not the right one.